MY151002A - Polyunsaturated fatty acid and diol ester as an anti-acne agent - Google Patents

Polyunsaturated fatty acid and diol ester as an anti-acne agent

Info

Publication number
MY151002A
MY151002A MYPI20112827A MY151002A MY 151002 A MY151002 A MY 151002A MY PI20112827 A MYPI20112827 A MY PI20112827A MY 151002 A MY151002 A MY 151002A
Authority
MY
Malaysia
Prior art keywords
fatty acid
polyunsaturated fatty
diol ester
acne agent
omega
Prior art date
Application number
Other languages
English (en)
Inventor
Redoules Daniel
Daunes-Marion Sylvie
Aries Marie-Françoise
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40875013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY151002(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MY151002A publication Critical patent/MY151002A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MYPI20112827 2008-12-22 2009-12-21 Polyunsaturated fatty acid and diol ester as an anti-acne agent MY151002A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0858967A FR2940281B1 (fr) 2008-12-22 2008-12-22 Ester de diol et d'acide gras polyinsature comme agent anti-acne

Publications (1)

Publication Number Publication Date
MY151002A true MY151002A (en) 2014-03-31

Family

ID=40875013

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20112827 MY151002A (en) 2008-12-22 2009-12-21 Polyunsaturated fatty acid and diol ester as an anti-acne agent

Country Status (26)

Country Link
US (1) US8623916B2 (enExample)
EP (1) EP2379484B1 (enExample)
JP (1) JP5587333B2 (enExample)
KR (1) KR101676055B1 (enExample)
CN (1) CN102256930B (enExample)
AU (1) AU2009331526B2 (enExample)
BR (1) BRPI0923494B1 (enExample)
CA (1) CA2747681C (enExample)
CL (1) CL2011001539A1 (enExample)
CO (1) CO6390033A2 (enExample)
ES (1) ES2424088T3 (enExample)
FR (1) FR2940281B1 (enExample)
GE (1) GEP20135820B (enExample)
IL (1) IL213646A (enExample)
MA (1) MA32810B1 (enExample)
MX (1) MX2011006659A (enExample)
MY (1) MY151002A (enExample)
NZ (1) NZ593781A (enExample)
PL (1) PL2379484T3 (enExample)
PT (1) PT2379484E (enExample)
RU (1) RU2524779C2 (enExample)
SG (1) SG172342A1 (enExample)
TN (1) TN2011000237A1 (enExample)
UA (1) UA103645C2 (enExample)
WO (1) WO2010072738A1 (enExample)
ZA (1) ZA201103509B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6336902B2 (ja) * 2011-06-22 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー.リミテッド コンジュゲートベースの抗真菌性および抗菌性プロドラッグ
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CA2920457A1 (en) * 2013-08-08 2015-02-12 Galderm Therapeutics Ltd. Anti-acne compositions comprising bile acid-fatty acid conjugates
FR3033135B1 (fr) * 2015-02-27 2018-03-16 Pierre Fabre Dermo-Cosmetique Association d'un retinoide et d'un ester de diol et d'acide gras polyinsature
FR3053253B1 (fr) * 2016-07-01 2020-01-17 Pierre Fabre Dermo-Cosmetique Nouvel extrait d'akenes de silybum marianum et ses utilisations en dermatologie et dermo-cosmetique

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5534762B2 (enExample) 1975-02-07 1980-09-09
DE4240674C2 (de) 1992-11-26 1999-06-24 Schuelke & Mayr Gmbh Desodorierende Wirkstoffe
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH09110818A (ja) * 1995-10-16 1997-04-28 Sanshin Chem Ind Co Ltd 1−エチル−3−(3−ジメチルアミノプロピル)カルボジイミド塩酸塩の製造方法
ES2176692T3 (es) 1996-02-21 2002-12-01 Stoa Sa Composiciones cosmeticas, dermofarmaceuticas o veterinarias para el tratamiento aseptico de la piel humana o animal.
GB9620248D0 (en) * 1996-09-26 1996-11-13 Scotia Holdings Plc Esters of unsaturated fatty acids
GB9622636D0 (en) 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
WO2001001980A1 (en) * 1999-07-06 2001-01-11 The Regents Of The University Of California Methods for the amelioration of neuropsychiatric disorders by inhibiting the inactivating transport of endogenous cannabinoid substances
GB9927629D0 (en) * 1999-11-24 2000-01-19 Croda Int Plc Compounds
ES2208498T3 (es) 2001-06-22 2004-06-16 SYMRISE GMBH & CO. KG Uso de 1,2-decanodiol contra germenes causantes de olores corporales desagradables.
US20070265352A1 (en) 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
DE10206759A1 (de) 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Synergistische Mischungen von 1,2-Alkandiolen
SE0301862D0 (sv) 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
DE102004031210A1 (de) * 2004-06-28 2006-02-09 Trommsdorff Gmbh & Co. Kg MLV-Kosmetikum
DE10341179A1 (de) 2003-09-06 2005-03-31 Beiersdorf Ag Wirkstoffkombination gegen Akne
US7935732B2 (en) 2004-04-08 2011-05-03 Isp Investments Inc. Antimicrobial compositions
ES2352744T3 (es) * 2004-04-27 2011-02-22 Akzo Nobel Coatings International Bv Pintura pigmentada que se desprende a tiras.
JP2006056795A (ja) * 2004-08-18 2006-03-02 Suntory Ltd 6−o−pufaアスコルビン酸エステルを含有する皮膚化粧料並びに飲食品
DE102006044849A1 (de) * 2006-09-22 2008-04-03 Symrise Gmbh & Co. Kg Dekonjugierte Alkadiensäureester als Riech- und/oder Aromastoffe

Also Published As

Publication number Publication date
FR2940281B1 (fr) 2011-04-01
RU2524779C2 (ru) 2014-08-10
UA103645C2 (uk) 2013-11-11
CA2747681A1 (fr) 2010-07-01
EP2379484B1 (fr) 2013-05-29
ES2424088T3 (es) 2013-09-27
JP5587333B2 (ja) 2014-09-10
FR2940281A1 (fr) 2010-06-25
ZA201103509B (en) 2012-01-25
TN2011000237A1 (fr) 2012-12-17
IL213646A0 (en) 2011-07-31
SG172342A1 (en) 2011-07-28
KR20110101152A (ko) 2011-09-15
IL213646A (en) 2014-03-31
CO6390033A2 (es) 2012-02-29
WO2010072738A1 (fr) 2010-07-01
BRPI0923494A2 (pt) 2016-01-26
CN102256930B (zh) 2014-03-12
PT2379484E (pt) 2013-08-22
CA2747681C (fr) 2017-05-16
RU2011128264A (ru) 2013-01-27
GEP20135820B (en) 2013-05-10
HK1163655A1 (en) 2012-09-14
MA32810B1 (fr) 2011-11-01
KR101676055B1 (ko) 2016-11-14
NZ593781A (en) 2013-02-22
JP2012513380A (ja) 2012-06-14
PL2379484T3 (pl) 2013-10-31
CN102256930A (zh) 2011-11-23
US8623916B2 (en) 2014-01-07
BRPI0923494B1 (pt) 2017-04-18
AU2009331526A1 (en) 2010-07-01
AU2009331526B2 (en) 2013-10-24
EP2379484A1 (fr) 2011-10-26
US20110230557A1 (en) 2011-09-22
MX2011006659A (es) 2011-07-12
CL2011001539A1 (es) 2011-10-14

Similar Documents

Publication Publication Date Title
WO2009150023A3 (de) Verfähren zur herstellung von sphingolipiden durch enzymatische n-acylierung von lysosphingolipiden unter verwendung einer lipase und eines fettsäureglycerinesters
WO2009150022A3 (de) Verfahren zur herstellung von sphingolipiden durch enzymatische n-acylierung von lysosphingolipiden unter verwendung einer pilz-lipase und eines fettsäurealkylesters
WO2010034917A3 (fr) Mono ester de n-undecylenoyl phenylalanine et de polyol, procede pour sa preparation et utilisation desdits esters comme agent eclaircissant la peau
MY191912A (en) Estolide compositions exhibiting high oxidative stability
WO2012130655A3 (de) Verfahren zur herstellung eines konditionierenden reinigungsmittels
EP2074079A4 (en) METATHESIS METHODS WITH HYDROGENATION, AND RELATED COMPOSITIONS THEREOF
MX368526B (es) Metodos y composiciones relacionados con tioesterasa enzima.
BR112012015501A2 (pt) "processo de biodegradação e composição"
MY151002A (en) Polyunsaturated fatty acid and diol ester as an anti-acne agent
MX340441B (es) Proceso para tratar fibras queratinicas alaciadas.
WO2011080208A9 (en) Amides, use of amides as solvents for organic compounds, compositions and emulsions containing amides, and method for treating a plant
MX339228B (es) Aditivos de nanoparticula y formulaciones de lubricante qe contienen los aditivos de nanoparticulas.
WO2012130656A3 (de) Verfahren zur herstellung eines konditionierenden reinigungsmittels
MX337560B (es) Composiciones de fragancia que comprenden mezclas especiales de diaestereomeros de 2 - isobutil - 4 - metil - tetrahidro - 2h -piran - 4 - ol.
UA96156C2 (ru) Эфиры докозагексаеновой кислоты и их применение для лечения и предупреждения сердечнососудистого заболевания
MY179145A (en) Skin cleansing composition
MY157705A (en) Emulsified fats and oils composition
BR112013001942A2 (pt) ester de ácidos carboxílicos hidróxi o-substituído, processo para produzir pelo menos um éster de ácidos hidróxi carboxílicos o-substituídos, e, composição cosmética
NZ601001A (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
BR112013031146A2 (pt) liberação direcionada de compostos retinóides para as glândulas sebáceas
MY167638A (en) Treatment composition for textile goods
NZ704155A (en) Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof
MX2013003387A (es) Proceso para preparacion de producto de reaccion de urea ciclica y de aldehido multifuncional.
GB2512777A (en) Fatty acid ester compositions for use as emollients
BR112014012078A8 (pt) método de preparação de uma espuma